FSD Pharma Inc. (HUGE)

0.3700 0.0000 (0.00%) At close: 04:00PM EDT

FSD Pharma Inc.

55 University Ave.
Suite 1003
Toronto, ON M5J 2H7
Canada

https://www.fsdpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Zeeshan Saeed	Founder, CEO, President & Executive Co-Chairman	222.62k	N/A	1970
Mr. Anthony John Durkacz	Founder & Executive Co-Chairman	222.62k	N/A	1976
Mr. Nathan Coyle CPA	Chief Financial Officer	178.21k	N/A	1981
Mr. Donal Carroll CPA	Chief Operating Officer	225.62k	N/A	1977
Dr. Lakshmi P. Kotra BPHARM, Ph.D.	CEO of Lucid & Director	144.72k	N/A	1971
Ms. Maryann Adesso	Corporate Secretary	N/A	N/A	N/A
Randell Mack	President of FSD BioSciences	N/A	N/A	N/A
Dr. Andrzej Chruscinski M.D., Ph.D.	Vice President of Clinical & Scientific Affairs of Lucid	110.3k	N/A	N/A
Mr. Kevin Cassidy	Vice President of Quality-Lucid	144.82k	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.

Corporate Governance

FSD Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.